Health Check: How Prudently Does PharmaResources (Shanghai) (SZSE:301230) Use Debt?

Simply Wall StNov 13 19:01 ET

Hongbo Pharmaceuticals (301230.SZ) shareholder Zhongfu Jishi completed a 1% shareholding reduction.

Announcement from Hongbo Pharmaceuticals (301230.SZ), the company's shareholder Peking Zhongfu Jishi Investment Center (Limited Partnership) (referred to as...

Zhitong FinanceNov 11 06:31 ET

Hongbo Pharmaceuticals (301230.SZ) plans to grant 1.23 million restricted stocks at a grant price of 12.35 yuan per share.

Hongbo Pharmaceutical (301230.SZ) disclosed the 2024 Restricted Stock Incentive Plan (draft), the company plans to award restricted stocks to incentivize employees, with a total of 400 participants participating.

Zhitong FinanceOct 31 07:13 ET

Hongbo Pharmaceutical: Report for the third quarter of 2024

SZSIOct 27 12:00 ET · Announcements

Hongbo Pharma (301230.SZ) released its performance for the first three quarters, with a net income of 15.2436 million yuan, a 66.81% year-on-year decrease.

Hongbo Medicine (301230.SZ) released the third quarter report for the first three quarters of 2024, during the reporting period the company achieved revenue...

Zhitong FinanceOct 27 06:43 ET

Hongbo Pharmaceuticals (301230.SZ): In the first half of 2024, a dividend of 1 yuan per 10 shares will be distributed. The ex-dividend date is October 24th.

Golden 汇October 17th丨Hongbo Pharmaceutical (301230.SZ) announced that the company's interim equity distribution plan for the first half of 2024 is as follows: based on the total share capital of the company, excluding the repurchased 2,046,200 shares, the remaining 137,540,405 shares will be distributed to all shareholders at a rate of 1.0 RMB cash per 10 shares. The equity registration date is October 23, 2024, and the ex-rights and ex-dividend date is October 24, 2024.

Gelonghui FinanceOct 17 05:21 ET